€300 million boost for biomedicine in Berlin

26 November 2012

Two of Berlin's largest biomedical research centres are merging to form the Berlin Institute of Health (BHI), a joint venture that will receive at least €300 million in new funding over the next five years.

This makes Berlin an even more significant and attractive research site, not only in the field of biomedicine. This is happening at the right time, according to Germany Trade & Invest, for an aging demographic means that there is an increasing demand for healthcare products and services.

"The BHI will make Berlin one of the world's top sites for medical excellence and will attract the world's best scientists and junior doctors. The partnership between the Berlin state and federal government has created an exemplary model of cooperation between university and non-university research. Germany has a globally recognized biomedical sector, and it will only improve due to the Institute's innovative models to train medical talent," said Dr. Sandra Bütow, chemical and health expert at Germany Trade & Invest.

Further information

Germany Trade & Invest is the foreign trade and inward investment agency of the Federal Republic of Germany. Germany is renowned for its effective public-private partnerships such as the Central Innovation Program SME, a country-wide support measure that provides sustainable support to the innovative capabilities and competiveness of small- and medium-sized enterprises. Participants include businesses and researchers from the health and wellness industry who collaborate in order to find innovative and value-added healthcare solutions.

Website: www.gtai.com